from The Market Digest by Robert Westfall Capricor Therapeutics Inc (CAPR) was Initiated by ROTH Capital to “Buy”. ROTH Capital advised their investors in a research report released on Jun 15, 2016. Capricor Therapeutics Inc opened for trading at $3.31 ...
Read More »